
WuXi XDC
Single-source ADC and bioconjugate discovery, development, and cGMP manufacturing CRDMO.
WuXi XDC is a leading CRDMO offering integrated discovery, development, and cGMP manufacturing services for antibody drug conjugates (ADCs) and bioconjugates, with proximately located facilities that reduce development timelines and costs. Headquartered in China.
Modalities
Development & manufacturing
Structured CDMO capabilities from verified public sources.
Development (D)
Manufacturing (M)
Biologics / bioreactor infrastructure
- Expression systems
- Mammalian
Fill-finish formats
Regulatory clearances
Services
- Monoclonal Antibody (mAb) Manufacturing
- Recombinant Protein Manufacturing
- ADC (Antibody-Drug Conjugate) Manufacturing
- ADC Payload & Linker Synthesis
- Bioconjugation Services
- Sterile Fill-Finish & Aseptic Manufacturing
- Vial Filling
- Lyophilization (Freeze Drying)
- Process Development
- Formulation Development
- Technology Transfer
- CMC Analytical Development
About this organization
Overview
WuXi XDC is a Contract Research, Development and Manufacturing Organization (CRDMO) specializing in antibody drug conjugates (ADCs) and broader bioconjugates. The company operates as a single-source platform with integrated, end-to-end capabilities across discovery, development, and cGMP manufacturing.
Key Capabilities
Bioconjugation Services:
- Bioconjugation discovery with R&D capabilities for ADC/bioconjugate generation, engineering, evaluation, and optimization
- Bioconjugation process development, scale-up, and tech-transfer to GMP manufacturing
- mAb intermediate and conjugation manufacturing from development batches through clinical and commercial supply
Drug Product Development & Manufacturing:
- Formulation and drug product development for liquid, frozen, and lyophilized dosage forms
- GMP formulation, fill, and lyophilization services with fully automated, isolator-based aseptic systems
- Vial filling capability for 2R, 6R, 10R, 20R, and 50R sizes for ADCs, bioconjugates, cytotoxic compounds, and small molecules
Chemical Intermediates:
- Payload and linker R&D and cGMP manufacturing for client-specified custom chemical intermediates
- Ready-to-conjugate off-the-shelf chemical payloads, linkers, and payload-linker intermediates
Analytical & Supporting Services:
- Analytical development with in-house expertise and state-of-the-art equipment
- Bioassay and biosafety laboratories supporting all development stages
- Characterization of protein/mAb, payload, linker, and bioconjugate intermediates
Market Position
WuXi XDC serves over 500 clients worldwide with more than 200 ongoing integrated CMC development programs and over 30 late-stage Phase II/III programs. The company has enabled over 100 successful INDs filed by clients. The proximity of facilities (within 1-2 hours drive) enables streamlined development that cuts development and manufacturing timelines in half.
Locations
Headquarters
China
Singapore Site
Singapore · Singapore
Recent news about WuXi XDC
Similar companies
Similar profiles by shared services, modalities, and capabilities.
Wheeler Bio- Monoclonal Antibody (mAb) Manufacturing
- Recombinant Protein Manufacturing
- AbbVie Contract Manufacturing
- Monoclonal Antibody (mAb) Manufacturing
- Recombinant Protein Manufacturing
Piramal Pharma Solutions- Monoclonal Antibody (mAb) Manufacturing
- Recombinant Protein Manufacturing
Abzena- Monoclonal Antibody (mAb) Manufacturing
- Recombinant Protein Manufacturing
Altruist Biologics- Monoclonal Antibody (mAb) Manufacturing
- Recombinant Protein Manufacturing
Carbogen Amcis- ADC (Antibody-Drug Conjugate) Manufacturing
- ADC Payload & Linker Synthesis
Samsung Biologics- Monoclonal Antibody (mAb) Manufacturing
- Recombinant Protein Manufacturing
- BSP Pharmaceuticals
- Monoclonal Antibody (mAb) Manufacturing
- Recombinant Protein Manufacturing
View all alternatives →See similar CDMOs ranked by shared capabilities
Submit a verified review for this organization.
Markdown mirror: /companies/wuxi-xdc.md